Brandon Oglensky, a senior equity research analyst at Barclays known for analyzing UPS, joins Jared Holes, Mizuho's health care equity strategist focusing on Viking Therapeutics, and Alex Sherman, a CNBC sports reporter. They discuss the current market's crucial charts as the Dow faces its fourth straight loss. A highlight is Viking's surge, driven by its promising obesity drug VX2735. The traders also explore the dynamics between delivery services like UPS and key industry trends, making for an insightful market analysis.
